Literature DB >> 3667567

Occurrence of sulfatide as a major glycosphingolipid in WHHL rabbit serum lipoproteins.

A Hara1, T Taketomi.   

Abstract

Glycosphingolipids in serum and lipoproteins from Watanabe hereditable hyperlipidemic rabbit (WHHL rabbit), which is an animal model for human familial hypercholesterolemia (FH), were analyzed for the first time in this study. Chylomicrons and very low density, low density, and high density lipoproteins contained sulfatide as a major glycosphingolipid (12 nmol/mumol total phospholipids (PL) in chylomicrons, 19 nmol/mumol PL in VLDL, 18 nmol/mumol PL in LDL, and 14 nmol/mumol PL in HDL) with other minor glycosphingolipids such as glucosylceramide, galactosylceramide, GM3 ganglioside, lactosylceramide, and globotriaosylceramide. The concentration of sulfatide as a major glycosphingolipid in WHHL rabbit serum (121 nmol/ml) was much higher than that in normal rabbit serum (3 nmol/ml). Fatty acids of the sulfatides comprised mainly nonhydroxy fatty acids (C22, 23, and 24) and significant amounts of hydroxy fatty acids (about 10%) whereas long chain bases of the sulfatides comprised mostly (4E)-sphingenine with a significant amount of 4D-hydroxysphinganine (about 10%). Furthermore, sulfatides in the liver and small intestine from normal and WHHL rabbits (where serum lipoproteins are produced) were determined to amount to 260 nmol/g liver in WHHL rabbit, 104 nmol/g liver in control rabbit, 99.6 nmol/g small intestine in WHHL rabbit, and 31.2 nmol/g small intestine in control rabbit. Ceramide portions of the sulfatides in the liver were mainly composed of (4E)-sphingenine and nonhydroxy fatty acids, while those in the small intestine were mainly composed of 4D-hydroxysphinganine and hydroxy fatty acids. These results indicated that the sulfatides of serum lipoproteins were mostly derived from the liver (90% of the total), and that the remaining sulfatides (10% of the total) might be derived from the small intestine. These two sulfatides, which have different ceramide portions, could be useful markers for metabolic and biosynthetic studies of various lipoproteins in WHHL rabbit, and thus would be helpful to further elucidate the relationship between hypercholesterolemia and atherosclerosis in the rabbit.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3667567     DOI: 10.1093/oxfordjournals.jbchem.a122044

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  13 in total

1.  Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model.

Authors:  M Kyogashima; J Onaya; A Hara; T Taketomi
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

2.  Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.

Authors:  Yuji Kamijo; Lixuan Wang; Akihiro Matsumoto; Takero Nakajima; Koji Hashimoto; Makoto Higuchi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Clin Exp Nephrol       Date:  2012-05-03       Impact factor: 2.801

3.  Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patients via processes correlated to oxidative stress and platelet count.

Authors:  Lixuan Wang; Yuji Kamijo; Akihiro Matsumoto; Takero Nakajima; Makoto Higuchi; Reiji Kannagi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Glycoconj J       Date:  2011-04-19       Impact factor: 2.916

4.  Separation of glycosphingolipids with titanium dioxide.

Authors:  Ayaka Noda; Miki Kato; Shota Miyazaki; Mamoru Kyogashima
Journal:  Glycoconj J       Date:  2018-10-04       Impact factor: 2.916

5.  Peroxisome proliferator-activated receptor α mediates enhancement of gene expression of cerebroside sulfotransferase in several murine organs.

Authors:  Takero Nakajima; Yuji Kamijo; Huang Yuzhe; Takefumi Kimura; Naoki Tanaka; Eiko Sugiyama; Kozo Nakamura; Mamoru Kyogashima; Atsushi Hara; Toshifumi Aoyama
Journal:  Glycoconj J       Date:  2012-10-13       Impact factor: 2.916

6.  Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure.

Authors:  Rui Hu; Gang Li; Yuji Kamijo; Toshifumi Aoyama; Takero Nakajima; Teruo Inoue; Koichi Node; Reiji Kannagi; Mamoru Kyogashima; Atsushi Hara
Journal:  Glycoconj J       Date:  2007-07-27       Impact factor: 2.916

7.  Chronic ethanol consumption decreases serum sulfatide levels by suppressing hepatic cerebroside sulfotransferase expression in mice.

Authors:  Hiroki Kanbe; Yuji Kamijo; Takero Nakajima; Naoki Tanaka; Eiko Sugiyama; Lixuan Wang; Zhong-Ze Fang; Atsushi Hara; Frank J Gonzalez; Toshifumi Aoyama
Journal:  Arch Toxicol       Date:  2013-09-25       Impact factor: 5.153

Review 8.  HDL: bridging past and present with a look at the future.

Authors:  Angelo M Scanu; Celina Edelstein
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

9.  Sulfatide prolongs blood-coagulation time and bleeding time by forming a complex with fibrinogen.

Authors:  A Hara; K Uemura; T Taketomi
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

10.  Hepatic Cerebroside Sulfotransferase Is Induced by PPARα Activation in Mice.

Authors:  Takefumi Kimura; Takero Nakajima; Yuji Kamijo; Naoki Tanaka; Lixuan Wang; Atsushi Hara; Eiko Sugiyama; Eiji Tanaka; Frank J Gonzalez; Toshifumi Aoyama
Journal:  PPAR Res       Date:  2012-05-07       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.